Mortality and Causes of Death in Ulcerative Colitis: Results from 20 Years of Follow-up in the IBSEN Study

Inflammatory Bowel Diseases

Volumn 22, Issue 1, 2016, Pages 141-145

  Hovde, Oistein ^a,b   Småstuen, Milada C ^c   Høivik, Marte L ^d   Bernklev, Tomm ^b,e   Huppertz Hauss, Gert ^e   Høie, Ole ^f   Jahnsen, Jørgen ^b,g   Stray, Njaal ^h   Henriksen, Magne ⁱ   Solberg, Inger C ^d   Moum, Bjørn A ^b,d  

^a INNLANDET HOSPITAL TRUST   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e TELEMARK HOSPITAL   (Norway)

^f Sorlandet Hospital   (Norway)

^g AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^h DIAKONHJEMMET HOSPITAL   (Norway)

ⁱ Østfold Hospital   (Norway)

Author keywords

causes of death; Key Words: ulcerative colitis; mortality; prospective study

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; MESALAZINE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; GASTROENTEROLOGIST; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWAY; PATIENT INFORMATION; POPULATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; ULCERATIVE COLITIS; UNIVERSITY HOSPITAL; CASE CONTROL STUDY; COLITIS, ULCERATIVE; COMPARATIVE STUDY; DISEASE COURSE; HEALTH CARE DELIVERY; RISK FACTOR; SURVIVAL RATE;

ADULT; CASE-CONTROL STUDIES; CAUSE OF DEATH; COLITIS, ULCERATIVE; DELIVERY OF HEALTH CARE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; NORWAY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84964644483     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000582     Document Type: Article

References (17)

1. Kim B, Park SJ, Hong SP, et al. Proximal disease extension and related predicting factors in ulcerative proctitis. Scand J Gastroenterol. 2014;49:177-183.
2. Moum B, Vatn MH, Ekbom E, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996;31:362-366.
3. Cosnes J, Gower-Roussau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785-1794.e4.
4. Winther KV, Jess T, Langholz E, et al. Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology. 2003;125:1576-1582.
5. Solberg IC, Vatn MH, Høie O, et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430-1438.
6. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431-440.
7. Moum B, Vatn MH, Ekbom A, et al. Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Digestion. 1995;56:377-381.
8. Henriksen M, Jahnsen J, Lygren I, et al. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol. 2006;41:1037-1043.
9. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-9.
10. Henriksen M, Prior P, Dew MJ, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12:543-550.
11. Gyde S, et al. Mortality in ulcerative colitis. Gastroenterology. 1982;83: 36-43.
12. Selinger CP, Leong RW. Mortality from inflammatory bowel diseases. Inflamm Bowel Dis. 2012;18:1566-1572.
13. Jess T, Gamborg M, Munkholm P, et al. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol. 2007;102:609-617.
14. Bernstein CN, Ng SC, Lakatos PL, et al. A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease. Inflamm Bowel Dis. 2013;19:2001-2010.
15. Sonnenberg A. Time trends of mortality from Crohn's disease and ulcerative colitis. Int J Epidemiol. 2007;36:890-899.
16. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041-1048.
17. Manninen P, Karvonen A-L, Huhtala H, et al. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: A follow-up of 20 years. J Crohns Colitis. 2013;7:e551-7.